Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood‐Brain Barrier to Treat Brain Diseases
LOS ANGELES--(BUSINESS WIRE)--Eos Biosciences, Inc. (Eos), a nanomedicines company developing an efficient and versatile nanobiologic particle-based platform technology (Eosomes), announced that the U.S. Patent and Trademark Office has granted Eos Biosciences Patent No. 10,183,078, relating to a novel approach of using HER3-targeted Eosomes as a shuttle system for transporting various classes of therapeutics across the [...]